Carlsmed, Inc. CARL

Company Overview

Carlsmed, Inc. (Nasdaq: CARL) is a U.S.-based medical technology company focused on personalized spine surgery solutions for patients with spinal deformities and degenerative spinal conditions. The company operates within the orthopedic medical device and spinal implant industries, developing patient-specific surgical planning platforms and implant systems intended to improve surgical precision and clinical outcomes. Carlsmed’s core commercial offering combines digital surgical planning, proprietary data analytics, and customized spinal implants produced through advanced manufacturing technologies, including 3D printing.

The company’s primary revenue drivers are its personalized spinal implant systems, surgical planning services, and related procedural solutions used by spine surgeons and healthcare systems. Carlsmed has positioned itself around the integration of artificial intelligence-enabled planning software with patient-matched implant manufacturing, which differentiates it from traditional spinal implant companies that primarily rely on standardized hardware inventories. Founded in California, the company evolved from a technology-focused startup into a commercial-stage spine platform company emphasizing data-driven personalization in complex spine procedures.